NEW YORK (GenomeWeb News) – Sunnyvale, Calif.-based Arrayit is opening a business based in Houston that will serve as a commercial arm for diagnostics that will run on the company's microarray platform.

The Arrayit Diagnostics subsidiary will promote and market tests using the microarray platform that are aimed at early-stage diagnostics. Arrayit currently is developing diagnostic tests for cancer, neurodegenerative disease, and other diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.